Ali-Jackson Kamil bought RIGL
May 25, 2024 · Form 4 insider transaction
Ali-Jackson Kamil bought 25,000 shares of Rigel Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$0.00
Total value
N/A
InsiderAli-Jackson Kamil
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 25, 2024
Filing dateMay 29, 2024
Shares owned after68,750
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.